Keyphrases
Randomized Clinical Trial
100%
Lysergic Acid Diethylamide
100%
Attention-deficit-hyperactivity-disorder, Treatment
100%
Placebo
50%
Symptom Score
50%
Attention-deficit Hyperactivity Disorder Symptoms
50%
Attention Deficit Hyperactivity Disorder
25%
Netherlands
12%
Placebo-controlled
12%
Trial Registration
12%
Twice Daily
12%
Potential Gains
12%
Maastricht University
12%
Between-group
12%
Outpatient Treatment
12%
Psychiatric Disorders
12%
Outpatient Setting
12%
Somatic Symptoms
12%
Exclusion Criteria
12%
Switzerland
12%
Moderate to Severe
12%
Severity Score
12%
University Hospital
12%
Clinical Global Impression
12%
Mixed Model Repeated Measures
12%
Placebo Groups
12%
Severe Symptoms
12%
Disorders Diagnosis
12%
Major Psychiatric Disorders
12%
Microdosing Psychedelics
12%
INIS
doses
100%
symptoms
100%
safety
100%
clinical trials
100%
adults
100%
lysergic acid
100%
universities
22%
data
11%
females
11%
comparative evaluations
11%
netherlands
11%
hospitals
11%
administration
11%
design
11%
interventions
11%
inclusions
11%
aged adults
11%
switzerland
11%
Medicine and Dentistry
Combination Therapy
100%
Randomized Clinical Trial
100%
Low Drug Dose
100%
Attention Deficit Disorder
100%
Lysergide
100%
Placebo
75%
Rating Scale
50%
Outpatient
25%
Mental Disorder
25%
Clinical Global Impression
12%
Somatic Disorder
12%
Microdosing
12%
Psychotomimetic
12%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Randomized Clinical Trial
100%
Attention Deficit Disorder
100%
Lysergide
100%
Placebo
75%
Psychotomimetic
12%
Microdosing
12%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
Lysergic Acid Diethylamide
100%
Placebo
75%
Mental Disorder
25%
Psychotomimetic
12%
Somatic Disorder
12%
Psychology
Attention Deficit Hyperactivity Disorder
100%
Rating Scale
57%